NCT00243867View on ClinicalTrials.gov

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Taxoprexin

Administered by intravenous infusion over 1 hour infusion

DRUG

Carboplatin

Administered by intravenous infusion over 30 minutes. Dosing was based on the Calvert formula: carboplatin dose (mg) = (Target AUC) x (glomerular filtration rate (GFR) + 25).

DRUG

Paclitaxel

Administered by intravenous infusion over 3 hour infusion

Trial Locations (1)

75201

US Oncology, Dallas

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY